International Journal of CAR T-Cell Therapy, a peer reviewed, open access published by Sunvalley Communication, the publisher of ADC Review | Journal of Antibody-drug Conjugates and Onco’Zine, is set to premiere in the Summer of 2021.
The International Journal of CAR T-Cell Therapy is part of the Physician’s Weekly Oncology Network, an oncology focused online publication, digital audio (broadcast and podcast) and education platform.
The Physician’s Weekly Oncology Network offers news, opinion, conference coverage and in-depth interviews with the most highly respected and internationally recognized oncology and hematology experts and Key Opinion Leaders who weigh in on landmark and practice changing research and trending topics affecting the oncology community.
The Physician’s Weekly Oncology Network also offers physicians and other healthcare professionals accredited Continuing Medical Education (CME) activities.
Submit a Manuscript
Submission of manuscripts and articles for inclusion in the International Journal of CAR T-cell Therapy opens in early 2021. Click on the links for more information:
Advertising and Sponsorship
For publishing, sponsoring or advertising opportunities with International Journal of CAR T-Cell Therapy, contact our sales team via email or click on the link.